Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 27, 2001 - Issue 10
Submit an article Journal homepage
849
Views
69
CrossRef citations to date
0
Altmetric
Research Article

Characterization of the Solubility and Dissolution Properties of Several New Rifampicin Polymorphs, Solvates, and Hydrates

Stanley Q. Henwood* Research Institute for Industrial Pharmacy, Potchefstroom University for Christian Higher Education, Potchefstroom, 2520, South Africa
,
Wilna Liebenberg Research Institute for Industrial Pharmacy, Potchefstroom University for Christian Higher Education, Potchefstroom, 2520, South Africa
,
Lourens R. Tiedt Laboratory for Microscopy, Potchefstroom University for Christian Higher Education, Potchefstroom, 2520, South Africa
,
Antonie P. Lötter Research Institute for Industrial Pharmacy, Potchefstroom University for Christian Higher Education, Potchefstroom, 2520, South Africa
&
Melgardt M. de Villiers College of Pharmacy, University of Louisiana at Monroe, 700 University Avenue, Monroe, LA, 71209, U.S.A.; Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, Louisiana, U.S.A.
, Ph.D.
Pages 1017-1030 | Published online: 30 Sep 2001

REFERENCES

  • Castro K. G. Newsletter: Tuberculosis Elimination. TB Notes 1999; 3: 1–2
  • World Health OrganizationWorld Health Organisation, Global Tuberculosis Programme, Report Global Tuberculosis ControlWHO/TB/98-237World Health Organization: Geneva, Switzerland 1998
  • Sterling T. R., Alwood K., Gachuhi R., Goggin W., Blazes D., Bishai W. R., Chaisson R. E. Relapse Rates After Short-Course (6-Month) Treatment of Tuberculosis in HIV-Infected and Uninfected Persons. AIDS 1999; 13(14)1899–1904
  • Mandell G. L., Petri W. A. Antimicrobial Agents: Drugs Used in the Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy. Goodman and Gilman's the Pharmacological Basis of Therapeutics, J. G. Hardman, L. E. Limbird. 9th Ed., McGraw-Hill, New York 1996; 1155–1174
  • National Department of Health, South AfricaStandard Treatment Guidelines and Essential Drug List for South AfricaNational Department of Health South Africa: Pretoria South Africa331 1996
  • Männistö P. Absorption of Rifampin from Various Preparations and Pharmaceutic Forms. Clin. Pharmacol. Ther. 1997; 21: 370–374
  • Jindal K. C., Chaudhary R. S., Singal A. K., Gangwal S. S., Khanna S. Effect of Particle Size on the Bioavailability and Dissolution Rate of Rifampicin. Indian Drugs 1994; 32: 100–107
  • Douglas J. G., McLeod M. J. Pharmacokinetic Factors in the Modern Drug Treatment of Tuberculosis. Clin. Pharmacokinet 1999; 37: 127–146
  • Ghabo S. A., Gognion M. M., Williamson M. J. Modified Dissolution Method for Rifampin. Drug Dev. Ind. Pharm. 1989; 15: 331–335
  • Ammar H. O., Khalil R. M. Discrepancy Among Dissolution Rates of Commercial Tablets as a Function of Dissolution Method. Die Pharm. 1996; 51: 165–168
  • Henwood S. Q., De Villiers M. M., Liebenberg W., Lötter A. P. Solubility and Dissolution Properties of Generic Rifampicin Raw Materials. Drug Dev. Ind. Pharm. 2000; 26: 403–408
  • Pelizza G., Nebuloni M., Ferrari P., Gallo G. G. Polymorphism of Rifampicin. Il Farmaco 1977; 32: 471–481
  • Gadret P. M., Goursolle M., Leger J. M., Colleter C. Structure Cristalline De La Rifampicine C43N4O12H58 · 5H2O. Acta Cryst. 1975; B31: 1454–1462
  • Gallo G. G., Radaelli P. Rifampin. Analytical Profiles of Drug Substances, K. Florey. Academic Press, New York 1976; 5: 467–513
  • Lötter A. P., Flanagan D. R., Palepu N. R., Guillory J. K. A Simple Reproducible Method for Determining Dissolution Rates of Hydrophobic Powders. Pharm. Technol. 1983; 7: 55–66
  • Moore J. W., Flanner H. H. Mathematical Comparison of Dissolution Profiles. Pharm. Technol. 1996; 20: 64–74
  • SUPAC-IR. Guidance for Industry: Chemistry, Manufacturing, and Controls, In-Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation. Rockville, MD 1995; 40, 1995
  • Food and Drug Administration. Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Forms; Food and Drug Administration. Rockville, MD 1997; 30
  • Ferrari P., Gallo G. G. Infrared Spectra of Rifamycins. Il Farmaco 1975; 30: 676–696
  • Brufani M., Cerrini S., Fedeli W., Vaciago A. Rifamycins: An Insight into Biological Activity Based on Structural Investigations. J. Mol. Biol. 1974; 87: 409–435

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.